A tale of two cinnamons: A comparative review of the clinical evidence of Cinnamomum verum and C. cassia as diabetes interventions

Objective: This review investigates the effectiveness of two cinnamon species, Cinnamomum verum and C. cassia, in diabetes management; their impact on related health conditions and relevant parameters in healthy individuals and safety issues. Methods: PubMed, Cochrane Library, and ScienceDirect were searched from 2000 up to April 2018 for clinical trials using either C. verum or C. cassia in controlling blood glucose and other diabetes-related parameters and conditions. Results: A total of twenty-five studies (n=997) were included for reviewing clinical evidence. Among these trials, fifteen studies investigated the effects on type II diabetes mellitus (T2DM) patients (n=831), four investigated subjects with related clinical conditions (n=82), and six investigated healthy individuals (n=84). Nineteen studies used C. cassia and six used C. verum. Results suggested C. cassia helped manage diabetes at 3-6g, while the effectiveness of C. verum remained inconclusive. In addition, the chemical properties of C. cassia and C. verum differ considerably. Of note, C. cassia contains high levels of the potentially hepatotoxic constituent coumarin. A skin rash was the only adverse event reported. Conclusion: While evidence supports the therapeutic benefit of C. cassia, interchangeability of C. cassia and C. verum remains inconclusive. Further research is warranted to address the effectiveness and safety of these cinnamon species. Given the potential hepatotoxicity of C. cassia, RCTs that include liver function tests are required. Robust RCTs on C. verum are recommended to establish if its efficacy can match its safety profile

Preliminary studies identifying and quantifying trace metal impurities in illicit ecstasy tablets using atomic spectrometry techniques

This paper illustrates some preliminary investigations into using ICP-MS in combination with ET-AAS in the analysis of Ecstasy tablets. Results indicate that a combination of both techniques can show discriminating power between seizures. Descriptions of the modifications made to optimise the ET-AAS system are described

Preventing Teen Dating Violence and Promoting Healthy Dating Relationships Among Adolescents Ages 12-18: An Evidence-Based Practice Guide for School Social Workers

This EBP guide is to help school social workers become familiar with the prevalence of teen dating violence, and learn some of the elements of unhealthy teen relationships. It also provides some guidance in promoting healthy relationship skills for adolescents ages 12-18, while promoting bystander intervention in teen dating violence. It can also be used as a resource for community members, families, and teens

Blaming the victim, all over again: Waddell and Aylward's biopsychosocial (BPS) model of disability

The biopsychosocial (BPS) model of mental distress, originally conceived by the American psychiatrist George Engel in the 1970s and commonly used in psychiatry and psychology, has been adapted by Gordon Waddell and Mansell Aylward to form the theoretical basis for current UK Government thinking on disability. Most importantly, the Waddell and Aylward version of the BPS has played a key role as the Government has sought to reform spending on out-of- work disability benefits. This paper presents a critique of Waddell and Aylward’s model, examining its origins, its claims and the evidence it employs. We will argue that its potential for genuine inter-disciplinary cooperation and the holistic and humanistic benefits for disabled people as envisaged by Engel are not now, if they ever have been, fully realized. Any potential benefit it may have offered has been eclipsed by its role in Coalition/Conservative government social welfare policies that have blamed the victim and justified restriction of entitlements

Valerian Root in Treating Sleep Problems and Associated Disorders—A Systematic Review and Meta-Analysis

Sleep problems are widely prevalent and associated with various comorbidities including anxiety. Valerian ( Valeriana officinalis L.) is a popular herbal medicine used as a sleep aid, however the outcomes of previous clinical studies are inconsistent. This study was conducted to update and re-evaluate the available data in order to understand the reason behind the inconsistent outcomes and to provide a broader view of the use of valerian for associated disorders. PubMed, ScienceDirect, and Cochrane Library were searched to retrieve publications relevant to the effectiveness of valerian as a treatment of sleep problems and associated disorders. A total of 60 studies (n=6,894) were included in this review, and meta-analyses were performed to evaluate the effectiveness to improve subjective sleep quality (10 studies, n=1,065) and to reduce anxiety (8 studies, n=535). Results suggested that inconsistent outcomes were possibly due to the variable quality of herbal extracts and that more reliable effects could be expected from the whole root/rhizome. In addition, therapeutic benefits could be optimized when it was combined with appropriate herbal partners. There were no severe adverse events associated with valerian intake in subjects aged between 7 and 80 years. In conclusion, valerian could be a safe and effective herb to promote sleep and prevent associated disorders. However, due to the presence of multiple active constituents and relatively unstable nature of some of the active constituents, it may be necessary to revise the quality control processes, including standardization methods and shelf life